Cargando…

The CRIPSR/Cas gene‐editing system—an immature but useful toolkit for experimental and clinical medicine

A Chinese scientist, Jiankui He, and his creation of the world's first genetically altered baby made headlines recently. As a newly developed gene‐editing technique, the CRISPR/Cas system should not be applied to human beings for reproductive purposes until it has been extensively tested. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuyan, Huang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431121/
https://www.ncbi.nlm.nih.gov/pubmed/31016281
http://dx.doi.org/10.1002/ame2.12061
Descripción
Sumario:A Chinese scientist, Jiankui He, and his creation of the world's first genetically altered baby made headlines recently. As a newly developed gene‐editing technique, the CRISPR/Cas system should not be applied to human beings for reproductive purposes until it has been extensively tested. However, numerous experimental research studies in human somatic, germline cells, and even in embryos, have been conducted, which have shown CRISPR/Cas to be a useful tool for human genome editing and a potential therapeutic method for future clinical use.